Company Analysis

MacroGenics, Inc. (MGNX)

Nasdaq: MGNX · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 2003
Grade5.6
◀ Past 6.3● Present 5.5▶ Future 4.9
1 est.

Who owns MacroGenics, Inc.

As filed with the SEC
Holders of 5% or more
2
Armistice Capital, LLC holds 7.88% of Common Stock, par value $0.01 per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
18
report now, of 26 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.01 per share · 9.46% in May 15, 2026
7.88%
Blackrock, Inc.
SCHEDULE 13G · filed Jul 29, 2026 · Common Stock · 2.9% in Jul 17, 2025
7.1%
Bank of America Corporation
SCHEDULE 13G/A · filed Aug 3, 2026 · Common Stock · reported falling below 5%, from 5.1% in May 14, 2026
under 5%
Millennium Management LLC
SCHEDULE 13G/A · filed Jul 20, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 5.4% in Jun 5, 2026
under 5%
Wasatch Advisors LP
SCHEDULE 13G/A · filed Nov 12, 2025 · COM · reported falling below 5%, from 5.6% in Feb 11, 2025
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
under 5%
Frazier Life Sciences Public Fund, L.P.
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 2.5% in Aug 14, 2025
under 5%
Bellevue Group AG
SCHEDULE 13G/A · filed Jan 6, 2026 · Common Stock · reported falling below 5%, from 15.7% in Jul 7, 2025
under 5%
BB Biotech AG
SCHEDULE 13G/A · filed Jun 13, 2025 · Common Stock · reported falling below 5%, from 15.8% in Feb 14, 2025
under 5%
RA Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%
under 5%
What MGNX reports owning in othersstakes of 5% or more, and other ties
MacroGenics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
1sales
0purchases
1sales on a scheduled plan
1people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 3, 2025 to Nov 3, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
17181920212223242526
2026 runs to Nov 3, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 28 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Peters Jeffrey StuartSenior VP, GC, and Secretary1$100,00010$0
SI Assistanton MGNX · research, not advice